Renaissance Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,496	Closed	-$288K	–	285
2019 Q3	$288K	Buy	10,496 +380	+4%	+$11.3K	0.01%	236
2019 Q2	$335K	Buy	10,116 +202	+2%	+$6.92K	0.01%	239
2019 Q1	$347K	Sell	9,914 -731	-7%	-$27.2K	0.01%	236
2018 Q4	$354K	Buy	10,645 +437	+4%	+$18.8K	0.02%	229
2018 Q3	$514K	Buy	10,208 +303	+3%	+$15K	0.02%	222
2018 Q2	$593K	Sell	9,905 -771	-7%	-$39.9K	0.02%	185
2018 Q1	$489K	Buy	10,676 +285	+3%	+$11.9K	0.02%	191
2017 Q4	$414K	Buy	10,391 +96	+0.9%	+$3.79K	0.01%	217
2017 Q3	$412K	Sell	10,295 -2,936	-22%	-$127K	0.01%	207
2017 Q2	$570K	Buy	13,231 +308	+2%	+$11K	0.02%	141
2017 Q1	$404K	Sell	12,923 -2,317	-15%	-$62.1K	0.02%	165
2016 Q4	$385K	Sell	15,240 -36	-0.2%	-$804	0.02%	175
2016 Q3	$378K	Sell	15,276 -1,921	-11%	-$43.5K	0.02%	164
2016 Q2	$350K	Sell	17,197 -3,829	-18%	-$67.9K	0.01%	173
2016 Q1	$321K	Buy	+21,026	New	+$274K	0.01%	173
2015 Q4	–	Sell	-19,873	Closed	-$279K	–	297
2015 Q3	$279K	Buy	+19,873	New	+$370K	0.01%	218